Teleflex Inc. (NYSE:TFX) shares hit a new 52-week high during trading on Friday . The stock traded as high as $184.01 and last traded at $181.98, with a volume of 50,117 shares trading hands. The stock had previously closed at $183.76.

TFX has been the subject of several research analyst reports. Leerink Swann boosted their price objective on shares of Teleflex from $183.00 to $190.00 and gave the company a “market perform” rating in a research report on Friday, July 29th. Zacks Investment Research cut shares of Teleflex from a “buy” rating to a “hold” rating in a research note on Thursday, May 5th. Barclays PLC reaffirmed an “overweight” rating and set a $183.00 target price (up previously from $170.00) on shares of Teleflex in a research note on Tuesday, June 14th. Raymond James Financial Inc. raised shares of Teleflex from an “outperform” rating to a “strong-buy” rating in a research note on Wednesday, June 1st. Finally, Brean Capital reaffirmed a “buy” rating and set a $168.00 target price (up previously from $157.00) on shares of Teleflex in a research note on Thursday, April 28th. Two research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company’s stock. Teleflex presently has an average rating of “Buy” and a consensus target price of $171.33.

The firm has a 50 day moving average of $179.91 and a 200 day moving average of $161.46. The firm has a market cap of $8.04 billion and a P/E ratio of 32.41.

Teleflex (NYSE:TFX) last released its quarterly earnings data on Thursday, July 28th. The medical technology company reported $1.89 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.74 by $0.15. During the same period last year, the business posted $1.42 earnings per share. The business earned $473.60 million during the quarter, compared to the consensus estimate of $468.40 million. The firm’s quarterly revenue was up 4.8% on a year-over-year basis. Equities analysts forecast that Teleflex Inc. will post $7.33 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Thursday, September 15th. Shareholders of record on Monday, August 15th will be paid a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 0.74%. The ex-dividend date of this dividend is Thursday, August 11th.

In other Teleflex news, Director Stuart A. Randle sold 797 shares of the stock in a transaction that occurred on Monday, June 6th. The shares were sold at an average price of $166.10, for a total value of $132,381.70. Following the sale, the director now directly owns 4,592 shares in the company, valued at approximately $762,731.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

An institutional investor recently raised its position in Teleflex stock. Schwab Charles Investment Management Inc. boosted its stake in Teleflex Inc. (NYSE:TFX) by 4.4% during the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 151,282 shares of the medical technology company’s stock after buying an additional 6,380 shares during the period. Schwab Charles Investment Management Inc. owned approximately 0.36% of Teleflex worth $19,887,000 as of its most recent filing with the SEC.

Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company markets and sells its products to hospitals and healthcare providers, across the world, through a combination of its direct sales force and distributors.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.